MRI evaluation of residual tumor size after neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy
European Journal of Radiology, 08/16/2012
Takeda K et al. – Contrast enhanced MRI enabled fairly accurate measurement in neoadjuvant endocrine therapy as well as in neoadjuvant chemotherapy.



